Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Thor Medical

Request full access

Supplier of high-purity alpha-emitting isotopes (Pb-212, Th-228, Ra-224) for targeted cancer therapies

Oslo, NorwayFounded 2009Biotech & Life Sciences

About Thor Medical

Thor Medical ASA is a Norwegian producer and supplier of high-purity alpha-emitting radioisotopes for the radiopharmaceutical industry. Its product portfolio comprises lead-212 (Pb-212) and its precursor isotopes thorium-228 (Th-228) and radium-224 (Ra-224), supplied to early-stage biotech companies, CDMOs and pharmaceutical companies developing targeted alpha therapies for cancer. The company's proprietary process applies separation technology to naturally occurring thorium (Th-232) and requires neither irradiation nor nuclear reactors.

After validating the process through pilot production and customer deliveries from 2024, Thor Medical started commercial production in July 2026 at AlphaOne, its industrial-scale facility at Herøya Industrial Park in Norway, and completed its first customer delivery from the plant, of Th-228, in August 2026. Capacity is planned to ramp up to around 21,000 patient dose equivalents after three years.

The listed company was founded in 2009 as Nordic Nanovector ASA, a developer of antibody-radionuclide conjugates for haematological cancers, whose lead candidate Betalutin was discontinued in 2022. On 3 July 2023 Nordic Nanovector completed the all-share acquisition of 100% of Thor Medical AS, founded in 2017 by Scatec Innovation, issuing 116,769,503 new shares to its shareholders, and was renamed Thor Medical ASA, trading on Oslo Børs under the ticker TRMED. The former Nordic Nanovector patent portfolio was transferred to NucliThera AS with effect from 1 December 2023, with Thor Medical retaining a profit-sharing interest. The company is headquartered in Oslo.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2015
Employees
23
Open positions
None listed
Dealroom signal
89.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Oncology, Drug Development, Spinout, Biotech and Pharma, Horizon Europe, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
1 company, latest Jun 2023
Capital deployed
—
Preferred round
ACQUISITION

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITYOther financing Jun 2025 $1.4M — Undisclosed ↗
PRIVATE PLACEMENT NON VCOther financing Jun 2025 $9.1M — Undisclosed ↗
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Thor Medical website traffic

Latest recorded traffic for Thor Medical is 3.6K monthly website visits, down 20% over the last three months. Thor Medical's team grew 43.8% over the past year.

Latest monthly visits3.6K 3-month web change-20% 1-year team growth+43.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Thor Medical in the Oslo ecosystem

Live from Dealroom

The Thor Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Birk Venture
  • Research Council of Norway

Other known investors3 additional known investors

  • Inven2
  • University of Oslo
  • HealthCap
Team profiled 19 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇳🇴 Norway100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Thor Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Thor Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.